Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Solar radiation and vitamin d: mitigating environmental factors in autoimmune disease.
Albumin and multiple sclerosis.
[Neuroprotective effect screening and the mechanism of 10 kinds of coumarin derivatives].
A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis.
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
[Electrophysiological examination of multiple sclerosis].
Pregnancy Data in a Turkish Multiple Sclerosis Population.
Fatigue, depression, and health-related quality of life in patients with multiple sclerosis in Isfahan, Iran.
High prevalence of abnormal gastrointestinal permeability in moderate-severe asthma.
CNS myelin structural modification induced in vitro by phospholipases A2.
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: No.
Therapy Adherence In Patients With Multiple Sclerosis Using An Electronic Multidose Auto-Injection Device.
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study.
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
Pages
« first
‹ previous
…
672
673
674
675
676
677
678
679
680
…
next ›
last »